#	Pagina
attuale pagina	/open-h2020/projects/194730/index.html
-1	/open-h2020/per-topic/polygonal/list/index.html
-2	/open-h2020/projects/212127/index.html
-3	/open-h2020/projects/214654/index.html
-4	/open-h2020/projects/224510/results.html
-5	/open-h2020/per-topic/issc/list/index.html
-6	/open-h2020/per-topic/sludges/list/index.html
-7	/open-h2020/per-topic/regulator/list/index.html
-8	/open-dormire/liguria/tipo/Alberghi+diffusi/index.html
-9	/open-h2020/per-topic/iga/list/index.html
-10	/open-consip/fornitori/2016/profilo-03371010921/index.html

Opendata, web and dolomites

Accellta

Accellta Market Study

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

Accellta project word cloud

Explore the words cloud of the Accellta project. It provides you a very rough idea of what is the project "Accellta" about.

neuronal patents drug screening despite huge expertise biomedical 3d 2012 companies grade customers infrastructure pioneering cells differentiated accellta reagents provider regenerative intellectual hpsc granted industrial services exceptional hpscs protected organizing free innovative personalised centre ip demands techniques suspension quantities proper plan national hold directives animal mass affordable culturing acknowledged therapies professionally utmost offers pluripotent medicine manner pharmaceutical technologies vision advancing sme clinical leader israel consultation establishment meeting newly ltd emerge promise lines succeeded property industry human remarkably license solutions company quality discoveries technion cardiomyocytes databases stem team premium direction market dated cell 1998

Project "Accellta" data sheet

The following table provides information about the project.

Coordinator	ACCELLTA LTD Organization address address: MALAT BUILDING - 3rd floor - TECHNION CITY city: HAIFA postcode: 3200004 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Israel [IL]
Project website	http://www.accellta.com
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.2.1.4. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology) 2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
Code Call	H2020-SMEINST-1-2014
Funding Scheme	SME-1
Starting year	2014
Duration (year-month-day)	from 2014-11-01 to 2015-04-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	ACCELLTA LTD ACCELLTA LTD Organization address address: MALAT BUILDING - 3rd floor - TECHNION CITY city: HAIFA postcode: 3200004 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IL (HAIFA)	coordinator	50˙000.00

Map

Project objective

Human pluripotent stem cells (hPSCs) and hPSCs-derived differentiated cells, such as cardiomyocytes and neuronal cells, are rapidly advancing discoveries in drug screening and development processes and hold much promise for personalised regenerative medicine. The affordable mass production of industrial-grade high quality hPSCs will enable meeting the research and clinical demands of the rapidly growing stem cell market. Accellta Ltd. offers a range of innovative solutions for culturing mass quantities of premium quality stem cells in a cost-effective manner. These solutions are the result of research dated since 1998 at the Stem Cell Centre at the Technion – Israel Institute of Technology. As a newly developed SME, this company has exceptional expertise in innovative hPSC culturing solutions, including growing stem cells in 3D suspension, with unique, animal-free reagents. These technologies are protected by numerous pioneering, granted and acknowledged patents and since its establishment in 2012. This SME already succeeded to license its IP to multi-national cell research companies. Accellta's future vision is to become a leading provider of premium quality differentiated cell lines and services to customers, which include pharmaceutical and biomedical companies. Despite the huge market potential, proper industry and market research plan is essential and organizing a professionally conducted study, using proper consultation and market research databases, is of the utmost importance. Understanding the market's direction and demands would provide the directives in which the company can proceed and find success. Accellta has the know-how, intellectual property, team and infrastructure required to emerge as a leader in this field. The company's remarkably unique techniques in pluripotent stem cell culturing would provide high quality hPSCs-derived differentiated cells will advance drug development and regenerative therapies.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ACCELLTA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ACCELLTA" are provided by the European Opendata Portal: CORDIS opendata.